| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/10/1997 | WO1997012633A1 Dendritic cell stimulatory factor |
| 04/10/1997 | WO1997012632A1 Methods for treatment of diseases associated with a deficiency of fas ligand activity |
| 04/10/1997 | WO1997012631A1 Drug for ameliorating renal function |
| 04/10/1997 | WO1997012630A1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer |
| 04/10/1997 | WO1997012629A1 Improved angiogenesis using hepatocyte growth factor |
| 04/10/1997 | WO1997012628A1 Methods and compositions for treating vascular stenosis |
| 04/10/1997 | WO1997012627A1 Therapeutic administration of hemoglobin in cardiac arrest |
| 04/10/1997 | WO1997012626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation |
| 04/10/1997 | WO1997012625A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 04/10/1997 | WO1997012624A1 Novel peptides |
| 04/10/1997 | WO1997012617A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | WO1997012601A2 Gel formulations containing growth factors |
| 04/10/1997 | WO1997012598A2 Dermatological and cosmetic compositions suitable for topical application, having modulating effect on the endogenous ceramide of the skin |
| 04/10/1997 | WO1997012527A2 Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | WO1997012526A1 Lactose-containing food composition for infants |
| 04/10/1997 | WO1997012519A1 Treatment of vascular injury |
| 04/10/1997 | WO1997009998A3 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 04/10/1997 | WO1997005250A3 Receptor ligand vegf-c |
| 04/10/1997 | WO1997000319A3 Chimeric leptin fused to immunoglobulin domain and use |
| 04/10/1997 | WO1996041868A3 Prothrombin derivatives |
| 04/10/1997 | WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 04/10/1997 | DE19608769C1 Monoclonal antibody BV10A4H2 specific for human FLT3/FLK2 receptor |
| 04/10/1997 | DE19537012A1 Cyclosporin(e) enhaltende pharmazeutische Zubereitung zur oralen Applikation und Verfahren zu ihrer Herstellung A cyclosporin (s) enhaltende pharmaceutical preparation for oral administration and processes for their preparation |
| 04/10/1997 | DE19535973A1 Medicament containing helodermin fragment |
| 04/10/1997 | DE19534602A1 Verwendung von Threonin zur Behandlung der Phenylketonurie Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | DE19534170C1 Recombinant polypeptide useful as immunostimulant and diagnostic tool |
| 04/10/1997 | CA2234229A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | CA2234061A1 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | CA2234059A1 Novel c-mpl receptor agonists |
| 04/10/1997 | CA2234045A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | CA2234042A1 Novel g-csf receptor agonists |
| 04/10/1997 | CA2233994A1 Novel platelet activation protein |
| 04/10/1997 | CA2233935A1 Process for isolating immunoglobulins in whey |
| 04/10/1997 | CA2233917A1 Therapeutic administration of hemoglobin in cardiac arrest |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2233859A1 Growth of adult pancreatic islet cells |
| 04/10/1997 | CA2233544A1 Combination temozolomide and alpha-ifn for the treatment of advanced cancer |
| 04/10/1997 | CA2233499A1 Treatment of vascular injury |
| 04/10/1997 | CA2233300A1 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | CA2233296A1 Compound having sequence homology with lipoprotein associated phospholipase a2 (lp-pla2)/paf acetyl hydrolase |
| 04/10/1997 | CA2233272A1 Novel peptides |
| 04/10/1997 | CA2232865A1 The use of flt3 ligand to generate dendritic cells |
| 04/10/1997 | CA2232315A1 Bifunctional sulfide-containing sulfonamide-chelating agents such as s2 ny for radioactive isotopes |
| 04/10/1997 | CA2232134A1 Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | CA2231505A1 Preparation of glucosaminyl muramic acid derivatives |
| 04/10/1997 | CA2230957A1 Regulated genes and uses thereof |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2206797A1 Novel membrane proteins of helicobacter pylori |
| 04/10/1997 | CA2206708A1 Novel membrane proteine p76 of helicobacter pylori |
| 04/10/1997 | CA2187485A1 Peptide and collagen contraction inhibitor |
| 04/09/1997 | EP0767178A1 Protein which induces interferon-gamma production by immunocompetent cell |
| 04/09/1997 | EP0766966A2 Method of treating insulin resistance |
| 04/09/1997 | EP0766965A1 Immunosuppressive agents |
| 04/09/1997 | EP0766745A1 Monoclonal antibody specific for human 4-1bb and cell line producing same |
| 04/09/1997 | EP0766741A1 Fusion proteins comprising gm-csf and antigens and their expression in yeast |
| 04/09/1997 | EP0766737A2 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
| 04/09/1997 | EP0766736A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 04/09/1997 | EP0766735A1 Class bi and ci scavenger receptors |
| 04/09/1997 | EP0766696A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 04/09/1997 | EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 04/09/1997 | EP0766694A1 Peptide derivatives with metallopeptidase inhibitory activity |
| 04/09/1997 | EP0766693A1 Novel parasite protease genes and proteins |
| 04/09/1997 | EP0766683A1 Novel substituted purinyl derivatives with immunomodulating activity |
| 04/09/1997 | EP0766570A1 Methods for treating respiratory disease |
| 04/09/1997 | EP0766569A1 Aav capsid vehicles for molecular transfer |
| 04/09/1997 | EP0766566A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/09/1997 | EP0766565A1 Medical use of bromelain |
| 04/09/1997 | EP0766564A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| 04/09/1997 | EP0766563A1 Agents affecting thrombosis hemostasis |
| 04/09/1997 | EP0766512A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 04/09/1997 | EP0666912B1 Modified ciliary neurotrophic factors |
| 04/09/1997 | EP0625911B1 Malaria treatments |
| 04/09/1997 | EP0606210B1 Hepatocyte growth stimulation with hepatocyte growth factor and gamma-interferon |
| 04/09/1997 | EP0597033B1 Igf-1 to improve the neural condition |
| 04/09/1997 | EP0588875B1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 04/09/1997 | EP0345359B1 Novel hydroxamic acid derivative |
| 04/09/1997 | CN1147261A Factor Xa inhibitors |
| 04/09/1997 | CN1147260A Neurokinine (tachykinine) antagonists |
| 04/09/1997 | CN1147205A Antithrombotic agents |
| 04/09/1997 | CN1146995A Thrombopoietin and its producing process |
| 04/09/1997 | CN1034506C Method for preparing medicinal composition contg. glycopeptide derivs. |
| 04/08/1997 | USRE35492 Wound treatment employing biologically active ion channel forming peptides and proteins |
| 04/08/1997 | US5618925 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 04/08/1997 | US5618924 BMP-2 products |
| 04/08/1997 | US5618922 NM03 antibody materials and methods |
| 04/08/1997 | US5618921 Antibodies for detection of human MDM2 protein |
| 04/08/1997 | US5618920 Immunoglobulins |
| 04/08/1997 | US5618919 Centrifuging whole blood in bowl-type centrifuge, separating erythrocytes from leukocytes, during centrifuging erythrocytes get disrupted forming endotoxin-free hemoglobin which is semi-synthetic blood-substitute |
| 04/08/1997 | US5618918 Human brain sodium dependent inorganic phosphate cotransporter |
| 04/08/1997 | US5618917 Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells |
| 04/08/1997 | US5618916 Purified protein which functions as a mycobacterial receptor for fibronectin |
| 04/08/1997 | US5618915 Increased inhibitory effect against serine protease; reduced nephrotoxicity, reduced positive net charge and reduced stability |
| 04/08/1997 | US5618914 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 04/08/1997 | US5618913 Insulin analogues |
| 04/08/1997 | US5618844 Matrix metalloproteinase inhibitor |
| 04/08/1997 | US5618823 Glutathione as chemoprotective agent |
| 04/08/1997 | US5618811 Gastrointestinal and central nervous system disorders |
| 04/08/1997 | US5618808 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/08/1997 | US5618792 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| 04/08/1997 | US5618791 Reduced side effects |